Delisting of Pharmaceutical Patents Challenged by the Federal Trade Commission

By afschroeder • May 12, 2026

Leon J, Tu SS, Kesselheim AS, Feldman WB. Delisting of Pharmaceutical Patents Challenged by the Federal Trade Commission. JAMA Intern Med. 2026 May 11. doi: 10.1001/jamainternmed.2026.0980. Epub ahead of print. PMID: 42113539.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply

Rana AI, Castillo-Mancilla J, Landovitz RJ. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply. N Engl J Med. 2026 May 14;394(19):1963-1964. doi:[...]

Prevalence, Progression, and Prognosis of Heart Stress In the Community: Implications for Heart Failure Prevention

Cai A, Liu L, Feng Y, Zhou Y, Li L, Bozkurt B, Januzzi JL, Lam CSP, Fonarow GC, Pandey A, Zhou Z, Cheng Y, Bayes-Genis[...]

Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-18F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study

Patel KK, Maddahi J, Agostini D, Bax JJ, Beanlands RSB, Berman D, Dorbala S, Heller GV, Knuuti JM, Pelletier-Galarneau M, Tamaki N, Thompson D, Somer[...]